Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.
Cell Chem Biol. 2024 May 16;31(5):944-954.e5. doi: 10.1016/j.chembiol.2024.03.010. Epub 2024 Apr 22.
Cell Chem Biol. 2024.
PMID: 38653243
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily.
Jhajj HS, Schardt JS, Khalasawi N, Yao EL, Lwo TS, Kwon NY, O'Meara RL, Desai AA, Tessier PM.
Jhajj HS, et al. Among authors: lwo ts.
bioRxiv [Preprint]. 2023 Dec 12:2023.12.11.571146. doi: 10.1101/2023.12.11.571146.
bioRxiv. 2023.
PMID: 38168220
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Unlocking the potential of agonist antibodies for treating cancer using antibody engineering.
Jhajj HS, Lwo TS, Yao EL, Tessier PM.
Jhajj HS, et al. Among authors: lwo ts.
Trends Mol Med. 2023 Jan;29(1):48-60. doi: 10.1016/j.molmed.2022.09.012. Epub 2022 Nov 4.
Trends Mol Med. 2023.
PMID: 36344331
Free PMC article.
Review.
Item in Clipboard
Agonist antibody discovery: Experimental, computational, and rational engineering approaches.
Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM.
Schardt JS, et al. Among authors: lwo ts.
Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24.
Drug Discov Today. 2022.
PMID: 34571277
Free PMC article.
Review.
Item in Clipboard
Cite
Cite